Bacterial Antigen Ingredients TRIZ Cases

Genetically modified Salmonella enteritidis vector delivers avian adenovirus type I fiber genes, resolving low efficacy of existing poultry vaccines.

Recombinant baculovirus expression of polyvalent VP2 mosaic VLPs replaces costly chick-based production to ensure antigen quality and manufacturing precision.

Plasma levitation prevents nucleation during solvent evaporation, achieving high conversion yields for low molecular weight drugs.

Ultrasound guidance targets adductor hallucis fascicles with botulinum toxin, reducing side effects from high-dose blanket injections.

Amino acid substitutions in secretin nanopores overcome poor DNA translocation efficiency caused by negative charges.

Fusion protein combines Rib and AlpC N-terminal regions to elicit protective immunity, resolving cross-reaction risks from polysaccharide vaccines.

Multi-parameter flow cytometry identifies specific CD4+ T-cell subsets to determine tuberculosis infection status.

NF-kB reporter assays identify Piericidin inhibitors that attenuate Yop secretion by 95% without mammalian toxicity.

Recombinant Bacillus vector delivers antigenic polypeptides to stimulate host immune responses.

Stimulate outer membrane vesicle release using elevated dissolved oxygen tension to boost vaccine precursor yield.

Recombinant outer membrane proteins from Brachyspira hyodysenteriae generate immune responses to prevent swine dysentery without complex diagnostics.

Combining pneumococcal saccharides with Haemophilus influenzae proteins reduces vaccination schedule complexity while maintaining broad pathogen coverage.

Chemically modified mycobacterial antigens overcome limited BCG duration by stimulating robust memory T cells and sustained antibody production.

Recombinant Fim and OmpA1 proteins stimulate protective immunity in channel catfish, reducing bacterial loads and mortality from virulent Aeromonas hydrophila.

Hydroxyapatite chromatography separates saccharide antigen-carrier protein conjugates from unconjugated carrier proteins via selective adsorption.

DNA vectors express immunogenic Emm proteins on tumor cells to stimulate anti-cancer immunity.

Live attenuated Bordetella bronchiseptica strain colonizes respiratory organs and induces protective antibody responses in livestock.

Composite vaccine targeting multiple bacterial virulence factors overcomes serotype variation limitations while neutralizing toxins to prevent laminitis.

Subtherapeutic parenteral interferon dosing activates immune cells to reduce tumor recurrence while avoiding severe systemic side effects.

Extracted surface proteins induce protective immunity against Streptococcus equi without causing side effects from whole bacteria.

Novel Neisseria meningitidis inner core lipo-oligosaccharide epitopes conjugated to carrier proteins induce broad cross-reactive immune responses.

MRE symbiotic bacteria generate immunostimulating substances to boost hen immunity, increasing Haugh unit and shell strength while reducing mortality.

A malaria vaccine combines a hybrid RTS,S antigen with 3D-MPL and QS21 adjuvants to elicit immune responses in infants.

LpxA and LpxD mutations reduce endotoxic activity in recombinant Bordetella pertussis, resolving reactogenicity issues while maintaining growth.